COLADONATO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 660
EU - Europa 126
AS - Asia 53
OC - Oceania 2
Totale 841
Nazione #
US - Stati Uniti d'America 657
SE - Svezia 54
CN - Cina 44
IT - Italia 22
FR - Francia 15
GB - Regno Unito 9
BE - Belgio 7
CZ - Repubblica Ceca 6
SG - Singapore 6
CA - Canada 3
DE - Germania 3
FI - Finlandia 3
IE - Irlanda 3
AU - Australia 2
UA - Ucraina 2
AT - Austria 1
ES - Italia 1
IN - India 1
IR - Iran 1
TR - Turchia 1
Totale 841
Città #
Fairfield 97
Chandler 92
Houston 50
Nyköping 50
Woodbridge 46
Ann Arbor 44
Cambridge 37
Seattle 36
Ashburn 35
Wilmington 31
Beijing 21
New York 15
Lawrence 14
Roxbury 12
Dearborn 8
Des Moines 8
Jacksonville 8
Brussels 7
Inglewood 7
San Diego 7
Brooklyn 5
Olomouc 5
Princeton 5
London 4
Dublin 3
Nanjing 3
Paris 3
Shenyang 3
Singapore 3
Toronto 3
Augusta 2
Bari 2
Boardman 2
Florence 2
Guangzhou 2
Hebei 2
Jinan 2
Jinhua 2
Nanchang 2
Saint-Fons 2
San Mateo 2
Washington 2
Ardabil 1
Brindisi 1
Brno 1
Canberra 1
Indiana 1
Jiaxing 1
Kilburn 1
Kunming 1
Leawood 1
Madrid 1
Melbourne 1
Mountain View 1
Mumbai 1
Redwood City 1
Trani 1
Vienna 1
Zhengzhou 1
Totale 703
Nome #
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 104
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 96
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 78
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 78
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 69
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 64
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. 58
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 56
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 56
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 47
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 45
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 43
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 34
Risk factors of damage in early diagnosed systemic lupus erythematosus: Results of the Italian multicentre Early Lupus Project inception cohort 22
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 14
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 8
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 5
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 2
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 2
Totale 881
Categoria #
all - tutte 4.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020256 22 5 3 12 21 32 40 31 35 27 15 13
2020/2021114 4 17 3 9 11 7 2 15 12 16 10 8
2021/2022119 4 4 2 6 8 9 8 4 8 9 18 39
2022/2023217 25 38 13 26 16 29 4 24 24 5 6 7
2023/202484 5 23 7 4 5 20 1 1 0 4 5 9
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 881